Showing results (51-60 of 254) with videos related to

Sort By:
Pageof 26
Clinical Genetics|January 1, 1979
alpha1-Antitrypsin deficiency in twins and parents-of-twinsJ Lieberman, N O Borhani, M Feinleib
Gene Therapy|January 7, 2006
The silent treatment: siRNAs as small molecule drugsD M Dykxhoorn, D Palliser, J Lieberman
The American Review of Respiratory Disease|January 1, 1976
A new deficient variant of alpha1-antitrypsin (MDUARTE). Inability to detect the heterozygous state by antitrypsin phenotypingJ Lieberman, L Gaidulis, S D Klotz
Current Opinion in Neurobiology|November 11, 2017
Synaptic plasticity may underlie l-DOPA induced dyskinesiaAnders Borgkvist, Ori J Lieberman, David Sulzer
Psychopharmacology. Supplementum|January 1, 1985
Tardive dyskinesia: prevalence, incidence, and risk factorsJ M Kane, M Woerner, J Lieberman
Journal of Clinical Psychopharmacology|August 1, 1988
Tardive dyskinesia: prevalence, incidence, and risk factorsJ M Kane, M Woerner, J Lieberman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2022
Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in deliriumOri J Lieberman, Seonjoo Lee, Jeffrey Zabinski
The American Journal of Medicine|January 1, 1977
Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype)A F Gelb, E Klein, J Lieberman
Clinical and Experimental Immunology|April 1, 1983
Circulating immune complexes in patients with diabetes mellitusC K Abrass, D Heber, J Lieberman
Pageof 26